Click Here for 5% Off Your First Aladdin Purchase!

Staurosporine - 98%, high purity , CAS No.62996-74-1, Inhibitor of calcium/calmodulin-dependent protein kinase II beta subunit;Inhibitor of death associated protein kinase 1;Inhibitor of homeodomain interacting protein kinase 1;Inhibitor of mitogen-activated protein kinase kinase 4;Inhibitor of mitogen-activ

  • Moligand™
  • ≥98%
Item Number
S102392
Grouped product items
SKUSizeAvailabilityPrice Qty
S102392-1mg
1mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$31.90
S102392-5mg
5mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$129.90

Protein kinase inhibitor

Basic Description

Synonymsstaurosporine|Staurosporin|62996-74-1|(+)-Staurosporine|Antibiotic 230|Antibiotic AM 2282|AM-2282|CCRIS 3272|Antibiotic AM-2282|Alkaloid AM-2282 from Streptomyces|(5S,6R,7R,9R)-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5H,14H-17-oxa-4b,9a
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsStaurosporine (Stsp) is potent inhibitor of protein kinase C (PKC) from rat brain, exhibiting an IC50 value of 2.7 nM. It inhibits rat recombinant PKC-α approximately 100- and 1,000-fold better than PKC-δ and PKC-ζ, respectively.2 However, Stsp is non-sel
Storage TempStore at 2-8°C
Shipped InWet ice
GradeMoligand™
Action TypeALLOSTERIC MODULATOR, INHIBITOR
Mechanism of actionInhibitor of calcium/calmodulin-dependent protein kinase II beta subunit;Inhibitor of death associated protein kinase 1;Inhibitor of homeodomain interacting protein kinase 1;Inhibitor of mitogen-activated protein kinase kinase 4;Inhibitor of mitogen-activ
NoteThis product is supplied in one (or more) pack size which is freeze dried. Therefore the contents may not be readily visible, as they can coat the bottom or walls of the vial. Please see our FAQs and information page for more details on handling. Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Staurosporine is a potent PKC inhibitor for PKCα, PKCγ and PKCη with IC50 of 2 nM, 5 nM and 4 nM, less potent to PKCδ (20 nM), PKCε (73 nM) and little active to PKCζ (1086 nM). Phase 3.

Associated Targets

CDK1 Tchem Cyclin-dependent kinase 1 4 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ERBB4 Tclin Receptor tyrosine-protein kinase erbB-4 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EPHB6 Tchem Ephrin type-B receptor 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ERBB2 Tclin Receptor tyrosine-protein kinase erbB-2 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EGFR Tclin Epidermal growth factor receptor 12 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CDK9 Tchem Cyclin-dependent kinase 9 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CDKL5 Tchem Cyclin-dependent kinase-like 5 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CDK18 Tchem Cyclin-dependent kinase 18 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CDK2 Tchem Cyclin-dependent kinase 2 8 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

FLT4 Tclin Vascular endothelial growth factor receptor 3 9 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

YES1 Tclin Tyrosine-protein kinase Yes 4 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TYK2 Tclin Non-receptor tyrosine-protein kinase TYK2 4 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

FLT3 Tclin Receptor-type tyrosine-protein kinase FLT3 32 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

FGFR2 Tclin Fibroblast growth factor receptor 2 6 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

FGFR3 Tclin Fibroblast growth factor receptor 3 8 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MET Tclin Hepatocyte growth factor receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

IGF1R Tclin Insulin-like growth factor 1 receptor 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PRKACG Tchem cAMP-dependent protein kinase catalytic subunit gamma 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TERT Tchem Telomerase reverse transcriptase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PLK4 Tchem Serine/threonine-protein kinase PLK4 5 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PIM1 Tchem Serine/threonine-protein kinase pim-1 15 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PIK3CG Tclin Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDGFRA Tclin Platelet-derived growth factor receptor alpha 8 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PIM2 Tchem Serine/threonine-protein kinase pim-2 7 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PIK3CB Tchem Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PIM3 Tchem Serine/threonine-protein kinase pim-3 5 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PRKG2 Tchem cGMP-dependent protein kinase 2 4 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

RPS6KA2 Tchem Ribosomal protein S6 kinase alpha-2 5 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PRKCH Tchem Protein kinase C eta type 6 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PRKD1 Tchem Serine/threonine-protein kinase D1 4 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

BTK Tclin Tyrosine-protein kinase BTK 5 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AURKA Tchem Aurora kinase A 19 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AURKB Tchem Aurora kinase B 13 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AAK1 Tchem AP2-associated protein kinase 1 3 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TNK2 Tclin Activated CDC42 kinase 1 4 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM4 Tclin Muscarinic acetylcholine receptor M4 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ACHE Tclin Acetylcholinesterase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ABL1 Tclin Tyrosine-protein kinase ABL1 10 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AKT2 Tchem RAC-beta serine/threonine-protein kinase 5 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AKT1 Tchem RAC-alpha serine/threonine-protein kinase 18 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CLK3 Tchem Dual specificity protein kinase CLK3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

BCHE Tclin Cholinesterase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GSK3B Tclin Glycogen synthase kinase-3 beta 18 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KIT Tclin Mast/stem cell growth factor receptor Kit 18 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

NTRK1 Tclin High affinity nerve growth factor receptor 10 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MTOR Tclin Serine/threonine-protein kinase mTOR 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one
INCHI InChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1
InChi Key HKSZLNNOFSGOKW-FYTWVXJKSA-N
Canonical SMILES CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC
Isomeric SMILES C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC
WGK Germany 3
PubChem CID 44259
Molecular Weight 466.53
Beilstein 1060573

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

2 results found

Lot NumberCertificate TypeDateItem
H1815136Certificate of AnalysisMar 06, 2024 S102392
H1815135Certificate of AnalysisMar 06, 2024 S102392

Safety and Hazards(GHS)

Pictogram(s) GHS06,   GHS08,   GHS09,   GHS07
Signal Danger
Hazard Statements

H351:Suspected of causing cancer

H373:Causes damage to organs through prolonged or repeated exposure

H413:May cause long lasting harmful effects to aquatic life

H302:Harmful if swallowed

H228:Flammable solid

H400:Very toxic to aquatic life

H410:Very toxic to aquatic life with long lasting effects

H300:Fatal if swallowed

H310:Fatal in contact with skin

H340:May cause genetic defects

H350:May cause cancer

H361:Suspected of damaging fertility or the unborn child

H361d:Suspected of damaging the unborn child

Precautionary Statements

P273:Avoid release to the environment.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P370+P378:In case of fire: Use ... to extinguish.

P210:Keep away from heat, hot surface, sparks, open flames and other ignition sources. - No smoking.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P240:Ground/bond container and receiving equipment.

P264:Wash hands [and …] thoroughly after handling.

P260:Do not breathe dust/fume/gas/mist/vapors/spray.

P281:Use personal protective equipment as required.

P241:Use explosion-proof [electrical/ventilating/lighting/.../] equipment.

P270:Do not eat, drink or smoke when using this product.

P391:Collect spillage.

P330:Rinse mouth.

P262:Do not get in eyes, on skin, or on clothing.

P361+P364:Take off immediately all contaminated clothing and wash it before reuse.

P203:Obtain, read and follow all safety instructions before use.

P301+P316:IF SWALLOWED: Get emergency medical help immediately.

P301+P317:IF SWALLOWED: Get medical help.

P318:if exposed or concerned, get medical advice.

P316:Get emergency medical help immediately.

P319:Get medical help if you feel unwell.

WGK Germany 3

Related Documents

References

1. Omura S, Iwai Y, Hirano A, Nakagawa A, Awaya J, Tsuchya H, Takahashi Y, Masuma R.  (1977)  A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization..  J Antibiot,  30  (4): (275-82).  [PMID:863788]
2. Rüegg UT, Burgess GM.  (1989)  Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases..  Trends Pharmacol Sci,  10  (6): (218-20).  [PMID:2672462]
3. Devaiah BN, Lewis BA, Cherman N, Hewitt MC, Albrecht BK, Robey PG, Ozato K, Sims 3rd RJ, Singer DS.  (2012)  BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain..  Proc Natl Acad Sci USA,  109  (18): (6927-32).  [PMID:22509028]
4. Sanders DW, Jumper CC, Ackerman PJ, Bracha D, Donlic A, Kim H, Kenney D, Castello-Serrano I, Suzuki S, Tamura T et al..  (2021)  SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation..  Elife,  10  (3): (589-97).  [PMID:33890572]
5. Budworth J, Gescher A.  (1995)  Differential inhibition of cytosolic and membrane-derived protein kinase C activity by staurosporine and other kinase inhibitors..  FEBS Lett,  362  (2): (139-42).  [PMID:7536688]
6. McKenzie BA et al..  (2020)  Activation of the executioner caspases-3 and -7 promotes microglial pyroptosis in models of multiple sclerosis..  J Neuroinflammation,  17  (253).  [PMID:32861242]
7. Lotsberg ML et al..  (2020)  AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells..  J Thorac Oncol,  15  (6): (973-999).  [PMID:32018052]
8. Wu N et al..  (2021)  Berberine ameliorates neuronal AD-like change via activating Pi3k/PGCε pathway..  Biofactors,  47  (4): (587-599).  [PMID:33740285]
9. Hofmann L et al..  (2018)  Characterization of small fiber pathology in a mouse model of Fabry disease..  Elife,    [PMID:30328411]
10. Tomasek T et al..  (2021)  Cell-free hemoglobin-mediated human lung microvascular endothelial barrier dysfunction is not mediated by cell death..  Biochem Biophys Res Commun,  556  (199-206).  [PMID:33848934]
11. Pacitto R et al..  (2017)  CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages..  J Leukoc Biol,  101  (3): (683-692).  [PMID:28250113]
12. Toth K et al..  (2019)  Encoding the ß-Arrestin Trafficking Fate of Ghrelin Receptor GHSR1a: C-Tail-Independent Molecular Determinants in GPCRs..  ACS Pharmacol Transl Sci,  (4): (230-246).  [PMID:32259059]
13. Bhattacharyya M et al..  (2020)  Flexible linkers in CaMKII control the balance between activating and inhibitory autophosphorylation..  Elife,    [PMID:32149607]
14. Le TM et al..  (2021)  Ex vivo Induction of Apoptotic Mesenchymal Stem Cell by High Hydrostatic Pressure..  Stem Cell Rev Rep,  17  (2): (662-672).  [PMID:33128169]
15. Bukong TN et al..  (2014)  Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90..  PLoS Pathog,  10  (10): (e1004424).  [PMID:25275643]
16. Qian L et al..  (2016)  Grb7 and Hax1 may colocalize partially to mitochondria in EGF-treated SKBR3 cells and their interaction can affect Caspase3 cleavage of Hax1..  J Mol Recognit,  29  (7): (318-33).  [PMID:26869103]
17. Le TM et al..  (2020)  Hydrostatic pressure can induce apoptosis of the skin..  Sci Rep,  10  (17594).  [PMID:33077833]
18. Avril M et al..  (2019)  Interplay of Plasmodium falciparum and thrombin in brain endothelial barrier disruption..  Sci Rep,  (13142).  [PMID:31511575]
19. Park YH et al..  (2016)  Involvement of AMPA Receptor and Its Flip and Flop Isoforms in Retinal Ganglion Cell Death Following Oxygen/Glucose Deprivation..  Invest Ophthalmol Vis Sci,  57  (2): (508-26).  [PMID:26868754]
20. Magerus-Chatinet A & Rieux-Laucat F.  (2017)  In Vitro Evaluation of the Apoptosis Function in Human Activated T Cells..  Methods Mol Biol,  1557  (33-40).  [PMID:28078580]
21. Nicholls SB et al..  (2011)  Mechanism of a genetically encoded dark-to-bright reporter for caspase activity..  J Biol Chem,  286  (28): (24977-86).  [PMID:21558267]
22. Hansel CS et al..  (2019)  Nanoneedle-Mediated Stimulation of Cell Mechanotransduction Machinery..  ACS Nano,  13  (3): (2913-2926).  [PMID:30829469]
23. Anderson CJ et al..  (2021)  Microbes exploit death-induced nutrient release by gut epithelial cells..  Nature,  596  (7871): (262-267).  [PMID:34349263]
24. Vasilevich AS et al..  (2020)  On the correlation between material-induced cell shape and phenotypical response of human mesenchymal stem cells..  Sci Rep,  10  (18988).  [PMID:33149200]
25. Le Vasseur M et al..  (2019)  Pannexin 2 Localizes at ER-Mitochondria Contact Sites..  Cancers (Basel),  11  (3):   [PMID:30862038]
26. Jabbari K et al..  (2021)  Protein Ligands in the Secretome of CD36+ Fibroblasts Induce Growth Suppression in a Subset of Breast Cancer Cell Lines..  Cancers (Basel),  13  (18):   [PMID:34572749]
27. Yadikar H et al..  (2020)  Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization..  PLoS One,  15  (7): (e0224952).  [PMID:32692785]
28. Langsfeld ES et al..  (2015)  The Deacetylase Sirtuin 1 Regulates Human Papillomavirus Replication by Modulating Histone Acetylation and Recruitment of DNA Damage Factors NBS1 and Rad51 to Viral Genomes..  PLoS Pathog,  11  (9): (e1005181).  [PMID:26405826]

Solution Calculators